Investigating how mutations in specific RNA regions affect cancer's ability to evade the immune system
Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion
This study is looking at how changes in a specific part of RNA might help cancer cells hide from the immune system, which could lead to new ways to improve cancer treatments and make them work better for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11015036 on NIH RePORTER |
What this research studies
This research focuses on understanding how mutations in the 3' untranslated regions (3'UTRs) of RNA can influence cancer cells' ability to escape detection by the immune system. By analyzing these mutations across various types of cancer, the study aims to uncover their role in tumor immune evasion and response to immunotherapy. The researchers will use advanced techniques, including spatial transcriptomics and bioinformatics, to identify and characterize these mutations, potentially leading to new biomarkers and therapeutic targets for cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with various types of cancer who are undergoing or considering immunotherapy.
Not a fit: Patients with early-stage cancers that do not involve immune evasion mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments by identifying new targets for immunotherapy and better patient stratification.
How similar studies have performed: Previous research has shown promise in targeting RNA mutations for cancer treatment, indicating that this approach may yield significant insights.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Vlachos, Ioannis — Beth Israel Deaconess Medical Center
- Study coordinator: Vlachos, Ioannis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.